DarioHealth Corp

For the period ended Dec 31, 2024. Filed Mar 10, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 10, 2025

DRIO$2.39+16.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Comprehensive Loss


· · Year ended
· · December 31,
	2024		2023
Revenues:
Services		$20,197		$13,084
Consumer hardware		6,843		7,268
Total revenues		27,040		20,352

Cost of revenues:
Services		3,606		4,679
Consumer hardware		5,139		5,303
Amortization of acquired intangible assets		5,028		4,386
Total cost of revenues		13,773		14,368

Gross profit		13,267		5,984

Operating expenses:
Research and development		$24,179		$20,248
Sales and marketing		26,350		23,785
General and administrative		20,482		18,140

Total operating expenses		71,011		62,173

Operating loss		57,744		56,189

Total financial expenses (income), net		(13,145)		3,174

Loss before taxes		44,599		59,363

Income Tax		(1,852)		64

Net loss		$42,747		$59,427

Deemed dividend (contribution)		$(1,765)		$4,084

Net loss attributable to common shareholders		$40,982		$63,511

Net loss per share:

Basic and diluted loss per share of common stock		$0.61		$1.93
Weighted average number of common stock used in computing basic and diluted net loss per share		49,039,410		28,371,979

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.